Form 8-K - Current report:
SEC Accession No. 0000950170-25-101974
Filing Date
2025-08-04
Accepted
2025-08-04 16:02:22
Documents
28
Period of Report
2025-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-20250804.htm   iXBRL 8-K 50058
2 EX-99.1 sndx-ex99_1.htm EX-99.1 266779
3 EX-99.2 sndx-ex99_2.htm EX-99.2 15134
4 GRAPHIC img199102934_0.jpg GRAPHIC 14374
5 GRAPHIC sndx-ex99_2s1.jpg GRAPHIC 137825
6 GRAPHIC sndx-ex99_2s2.jpg GRAPHIC 762873
7 GRAPHIC sndx-ex99_2s3.jpg GRAPHIC 368666
8 GRAPHIC sndx-ex99_2s4.jpg GRAPHIC 316648
9 GRAPHIC sndx-ex99_2s5.jpg GRAPHIC 360411
10 GRAPHIC sndx-ex99_2s6.jpg GRAPHIC 279523
11 GRAPHIC sndx-ex99_2s7.jpg GRAPHIC 244029
12 GRAPHIC sndx-ex99_2s8.jpg GRAPHIC 282863
13 GRAPHIC sndx-ex99_2s9.jpg GRAPHIC 362836
14 GRAPHIC sndx-ex99_2s10.jpg GRAPHIC 475299
15 GRAPHIC sndx-ex99_2s11.jpg GRAPHIC 451719
16 GRAPHIC sndx-ex99_2s12.jpg GRAPHIC 339627
17 GRAPHIC sndx-ex99_2s13.jpg GRAPHIC 397373
18 GRAPHIC sndx-ex99_2s14.jpg GRAPHIC 259105
19 GRAPHIC sndx-ex99_2s15.jpg GRAPHIC 90394
  Complete submission text file 0000950170-25-101974.txt   7546354

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sndx-20250804.xsd EX-101.SCH 24852
30 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20250804_htm.xml XML 4682
Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 251180127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)